Buscar
Resultados de la búsqueda
- An Observational Study to Evaluate the Real-World Clinical Management and Outcomes of ALK-Positive Advanced NSCLC Participants Treated With Alectinib
-
... Medical Doctor, First degree specialist in oncology Affiliation: ... Havana, National Institute of Oncology and Radiobiology (INOR), Dra. Yoanna Flores, Medical Doctor, First ...
Clinical Trials - ROCHE - 31/08/2021 - 10:58am
- Un estudio observacional para evaluar el manejo clínico y los resultados en el mundo real de los participantes de CPCNP avanzado ALK positivos tratados con alectinib
-
... instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365–76. Arbour KC, Riely GJ. Diagnosis ... Cancer Network® (NCCN) Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Non-Small Cell Lung Cancer. Version 3.2020 – 11 ...
Ensayos Clínicos - ROCHE - 31/08/2021 - 10:57am
- Estudio para evaluar la preferencia de los pacientes y la satisfacción de la administración subcutánea de la combinación de dosis fija de Pertuzumab y Trastuzumab en participantes con cáncer de mama temprano positivo a HER2
-
... randomised multicentre, open-label, phase 2 trial. Lancet Oncology 2012;13(1):25-32. Gianni L, Pienkowski T, Im YH et al. 5-Year ... BO, Aft R et al. NCCN clinical practice guidelines in oncology (NCCN Guidelines®). Breast Cancer. Version I.2018 [internet]. ...
Ensayos Clínicos - ROCHE - 18/08/2021 - 6:58pm
- Estudio para describir el diagnóstico, el tratamiento contra el cáncer y el resultado clínico en pacientes con cáncer de mama recién diagnosticado en América Latina
-
... Latin American Cooperative Oncology Group (LACOG) Promotor ... Latin American Cooperative Oncology Group (LACOG) Participación del ...
Ensayos Clínicos - ROCHE - 18/08/2021 - 6:47pm
- A Study to Evaluate Patient Preference and Satisfaction of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Participants With HER2-Positive Early Breast Cancer
-
... Medical Doctor, Second degree specialist in oncology Affiliation: ... Havana, National Institute of Oncology and Radiobiology (INOR), Dr. Elías Gracia Medina, Medical Doctor, ...
Clinical Trials - ROCHE - 18/08/2021 - 6:13pm
- A Study to Describe the Diagnosis, Anti-Cancer Treatment and Clinical Outcome in Patients With Newly Diagnosed Breast Cancer in Latin America
-
... Latin American Cooperative Oncology Group (LACOG) Primary ... Latin American Cooperative Oncology Group (LACOG) Source(s) of monetary ...
Clinical Trials - ROCHE - 18/08/2021 - 6:07pm
- NAcGM3/VSSP/Montanide ISA 51 formulation in HIV, phase II.
-
... First Degree Specialist in Oncology Affiliation: ... First Degree Specialist in Oncology Affiliation: ...
Clinical Trials - CIM - 19/04/2021 - 3:41pm
- VSSP in renal cell carcinoma
-
... First grade specialist in Oncology Affiliation: ...
Clinical Trials - CIM - 08/04/2021 - 4:19pm
- Inmunoterapia con la combinación de NGcGM3/VSSP y nimotuzumab en pacientes con cáncer avanzado de pulmón de células no pequeñas (CPCNP)
-
... NGcGM3. 7. Estado general según el Eastern Cooperative Oncology Group (ECOG) menor igual 2. 8. Pacientes con expectativa de vida de ... 1995;14:350. 9. NCCN Clinical Practice Guidelines in Oncology. NSCLC. Version I.2013 www.nccn.org 10. Thongprasert S, Sanguanmitra ...
Ensayos Clínicos - CIM - 21/12/2020 - 11:38am
- Combined NGcGM3/VSSP and Nimotuzumab in advanced non-small cell lung cancer (NSCLC)
-
... Havana, “National Institute of Oncology and Radiobiology". Yoanna Ivette Flores Vega, MD. First degree specialist in Oncology Research ethics committees: ...
Clinical Trials - CIM - 21/12/2020 - 11:38am